Skip to Content

Global X Genomics & Biotechnology ETF GNOM

Medalist Rating as of | See Global X Investment Hub

Morningstar’s Analysis GNOM

Will GNOM outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Strength in Global X Genomics& Biotechnology ETF's People Pillar is partially offset by an Average Process Pillar rating, leading to a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings GNOM

  • Current Portfolio Date
  • Equity Holdings 41
  • Bond Holdings 0
  • Other Holdings 2
  • % Assets in Top 10 Holdings 44.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector
5.43
9,608,381
Healthcare
4.95
8,764,060
Healthcare
4.44
7,859,980
Healthcare
4.35
7,701,244
Healthcare
4.29
7,599,194
Healthcare
4.21
7,456,182
Healthcare
4.19
7,422,886
Healthcare
4.18
7,395,438
Healthcare
4.08
7,216,154
Healthcare
4.05
7,176,648
Healthcare